The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Adoptive regulatory T‐cell therapy protects against cerebral ischemia
Open accessAbstract
Objective: Recent evidence suggests that functional deficiency in regulatory T cells (Tregs), an innate immunomodulator, exacerbates brain damage after cerebral ischemia. We therefore evaluated the effect of Treg transfer in rodent models of ischemic stroke and further investigated the mechanism underlying Treg‐afforded neuroprotection. Methods: We examined the therapeutic potential of Tregs and the mechanisms of neuroprotection in vivo in 2 rodent models of ischemic stroke and in vitro in Treg–neutrophil cocultures using a combined approach including cell‐specific depletion, gene knockout mice, and bone marrow chimeras. Results: Systemic administration of purified Tregs at 2, 6, or even 24 hours after middle cerebral artery occlusion resulted in a marked reduction of brain infarct and prolonged improvement of neurological functions lasting out to 4 weeks. Treg‐afforded neuroprotection was accompanied by attenuated blood–brain barrier (BBB) disruption during early stages of ischemia, decreased cerebral inflammation, and reduced infiltration of peripheral inflammatory cells into the lesioned brain. Surprisingly, Tregs exerted early neuroprotection without penetrating into the brain parenchyma or inhibiting the activation of residential microglia. Rather, both in vivo and in vitro studies demonstrated that Tregs suppressed peripheral neutrophil‐derived matrix metallopeptidase‐9 production, thus preventing proteolytic damage of the BBB. In addition to its potent central neuroprotection, Treg treatment was shown to ameliorate poststroke lymphopenia, suggesting a beneficial effect on immune status. Interpretation: Our study suggests that Treg adoptive therapy is a novel and potent cell‐based therapy targeting poststroke inflammatory dysregulation and neurovascular disruption. Ann Neurol 2013;74:458–471
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596 · cited 1×
“Ischemic stroke elicits profound inflammatory response involving both innate and adaptive immunity.(1) Innate immune cells such as neutrophils and microglia/macrophages respond promptly to cerebral ischemia and migrate to the injury.”
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., & Caton, A. J. (2001) · Nature Immunology · doi:10.1038/86302 · Cited by 1,660
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
Prass, K., Meisel, C., Höflich, C., Braun, J., Halle, E., Wolf, T., Ruscher, K., Victorov, I. V., Priller, J., Dirnagl, U., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021098 · Cited by 925
Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1999 · Cited by 842
Role of T Lymphocytes and Interferon-γ in Ischemic Stroke
Yilmaz, G., Arumugam, T. V., Stokes, K. Y., & Granger, D. N. (2006) · Circulation · doi:10.1161/circulationaha.105.593046 · Cited by 722
Rosell, A., Cuadrado, E., Ortega-Aznar, A., Hernández-Guillamon, M., Lo, E. H., & Montaner, J. (2008) · Stroke · doi:10.1161/strokeaha.107.500868 · Cited by 577
Webster, K. E., Walters, S., Kohler, R. E., Mrkvan, T., Boyman, O., Surh, C. D., Grey, S. T., & Sprent, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082824 · Cited by 514
Matsuo, Y., Onodera, H., Shiga, Y., Nakamura, M., Ninomiya, M., Kihara, T., & Kogure, K. (1994) · Stroke · doi:10.1161/01.str.25.7.1469 · Cited by 485
Gidday, J. M., Gasche, Y. G., Copin, J.-C., Shah, A. R., Perez, R. S., Shapiro, S. D., Chan, P. H., & Park, T. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01275.2004 · Cited by 483
Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke
Rosell, A., Ortega-Aznar, A., Alvarez-Sabín, J., Fernández-Cadenas, I., Ribó, M., Molina, C. A., Lo, E. H., & Montaner, J. (2006) · Stroke · doi:10.1161/01.str.0000223001.06264.af · Cited by 439
Beers, D. R., Henkel, J. S., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 424
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 420
Offner, H., Subramanian, S., Parker, S. M., Wang, C., Afentoulis, M. E., Lewis, A., Vandenbark, A. A., & Hurn, P. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6523 · Cited by 410
Zhao, X., Sun, G., Zhang, J., Strong, R., Song, W., Gonzales, N., Grotta, J. C., & Aronowski, J. (2007) · Annals of Neurology · doi:10.1002/ana.21097 · Cited by 369
Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., & Giffard, R. G. (2006) · Stroke · doi:10.1161/01.str.0000206281.77178.ac · Cited by 359
Kleinschnitz, C., Schwab, N., Kraft, P., Hagedorn, I., Dreykluft, A., Schwarz, T., Austinat, M., Nieswandt, B., Wiendl, H., & Stoll, G. (2010) · Blood · doi:10.1182/blood-2009-10-249078 · Cited by 358
Golshayan, D., Jiang, S., Tsang, J., Garin, M. I., Mottet, C., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-05-025460 · Cited by 313
Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells
Taams, L. S., van Amelsfort, J. M. R., Tiemessen, M. M., Jacobs, K. M. G., de Jong, E. C., Akbar, A. N., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.006 · Cited by 289
Where CD4 + CD25 + T reg cells impinge on autoimmune diabetes
Chen, Z., Herman, A. E., Matos, M., Mathis, D., & Benoist, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051409 · Cited by 268
Justicia, C., Panés, J., Solé, S., Cervera, Á., Deulofeu, R., Chamorro, Á., & Planas, A. M. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090680.07515.c8 · Cited by 262
Stirling, D. P., Liu, S., Kubes, P., & Yong, V. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4918-08.2009 · Cited by 231
Wright, G. P., Notley, C. A., Xue, S.-A., Bendle, G. M., Holler, A., Schumacher, T. N., Ehrenstein, M. R., & Stauss, H. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907396106 · Cited by 213
Machado, L. S., Kozak, A., Ergul, A., Hess, D. C., Borlongan, C. V., & Fagan, S. C. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-56 · Cited by 193
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release
Cuadrado, E., Ortega, L., Hernández‐Guillamón, M., Peñalba, A., Fernández‐Cadenas, I., Rosell, A., & Montaner, J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907606 · Cited by 176
Saver, J., Albers, G., Dunn, B., Johnston, K., & Fisher, M. (2009) · Stroke · doi:10.1161/strokeaha.109.552554 · Cited by 159
Chakrabarti, S., Zee, J. M., & Patel, K. D. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605353 · Cited by 149
Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats
Park, K., Rosell, A., Foerch, C., Xing, C., Kim, W. J., Lee, S., Opdenakker, G., Furie, K. L., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.109.554824 · Cited by 141
CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke
Ren, X., Akiyoshi, K., Vandenbark, A., Hurn, P., & Offner, H. (2010) · Metabolic brain disease · doi:10.1007/s11011-010-9226-6 · Cited by 121
Immune activation in the peripheral blood of patients with acute ischemic stroke
Yan, J., Greer, J. M., Etherington, K., Cadigan, G., Cavanagh, H., Henderson, R. D., O’Sullivan, J. D., Pandian, J. D., Read, S. J., & McCombe, P. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.11.001 · Cited by 111
Zhang, R., Xue, Y., Lu, S., Wang, Y., Zhang, L., Huang, Y.-L., Signore, A. P., Chen, J., & Sun, F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.012 · Cited by 106
Self-citationKoh, S., Chang, D., Kim, H.-T., Kim, J., Kim, M., Kim, K. S., Bae, I., Kim, H., Kim, D. W., & Kim, S. H. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.023 · Cited by 67
Hombach, A. A., Kofler, D. M., Hombach, A., Rappl, G., & Abken, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7924 · Cited by 60
Ishimaru, N., Yamada, A., Kohashi, M., Arakaki, R., Takahashi, T., Izumi, K., & Hayashi, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6997 · Cited by 30
Cited by
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita, G., Racchumi, G., Ling, L., Pamer, E. G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4068 · Cited by 1,114
Inflammation and Stroke: An Overview
Anrather, J., & Iadecola, C. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0483-x · Cited by 958
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
Self-citationNeuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657
Metadata
- Authors
- Li, P., Gan, Y., Sun, B., Zhang, F., Lu, B., Gao, Y., Liang, W., Thomson, A. W., Chen, J., & Hu, X.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-05-14
- Volume
- 74
- Issue
- 3
- Pages
- 458-471
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1946941723
- Cited by
- 308
- References
- 38
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.